microRNA-449家族通过靶向SOX4抑制TGF-β介导的肝癌细胞迁移
该研究在体外实验和异种移植小鼠模型中分析miR-449a、miR-449b和miR-449c对肝癌的功能效应与靶基因,并在61例原发人肝癌与正常肝组织中验证靶基因表达。结果显示三者均直接靶向SOX4并抑制TGF-β介导的细胞迁移,其中miR-449a和miR-449b作用更强,作者认为尤其miR-449a和miR-449b可考虑用于miRNA替代治疗。
要点
- miR-449a、miR-449b与miR-449c的抑癌效应、结合特异性、靶基因和调控通路存在差异。
- 三者均直接靶向SOX4,从而抑制TGF-β介导的肝癌细胞迁移,miR-449c作用较弱。
- 作者认为尤其miR-449a和miR-449b可考虑用于miRNA替代治疗以阻止HCC进展和转移。
核心结论
- 本研究深入揭示表观遗传调控的miR-449家族的调控网络,并首次描述miR-449a、miR-449b和miR-449c各自不同的抑癌效应和靶点特异性。
- 结果提示尤其miR-449a和miR-449b可考虑用于miRNA替代治疗,以阻止HCC进展和转移。
研究设计与样本
- 在转染miR-449a、miR-449b和/或miR-449c后,用体外实验和异种移植小鼠模型分析肿瘤相关功能效应。
- 通过微阵列分析鉴定各miRNA的结合特异性、靶基因和调控通路,并用荧光素酶报告基因实验和体外表达分析验证靶基因。
- 在61例原发人肝癌与正常肝组织中比较靶基因表达。
主要发现
- miR-449a和miR-449b的抑癌效应、结合特异性、靶基因和调控通路与miR-449c不同。
- 转染miR-449a、miR-449b和/或miR-449c以不同程度抑制细胞增殖和迁移、诱导凋亡并减少肿瘤生长。
- miR-449a、miR-449b以及作用较弱的miR-449c直接靶向SOX4,SOX4编码参与上皮-间质转化和HCC转移的转录因子,从而抑制TGF-β介导的细胞迁移。
临床怎么用
- 作者认为尤其miR-449a和miR-449b可考虑用于miRNA替代治疗,以阻止HCC进展和转移。
- 作者结论认为microRNA-449家族可能成为肝癌治疗的靶点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Modulation of microRNA expression is a potential treatment for hepatocellular carcinoma (HCC). Therefore, the epigenetically regulated microRNA-449 family (miR-449a, miR-449b, miR-449c) was characterized with regards to its functional effects and target genes in HCC. METHODS: After transfection of miR-449a, miR-449b, and/or miR-449c, tumor-relevant functional effects were analyzed using in vitro assays and a xenograft mouse model. Binding specificities, target genes, and regulated pathways of each miRNA were identified by microarray analyses. Target genes were validated by luciferase reporter assays and expression analyses in vitro. Furthermore, target gene expression was analyzed in 61 primary human HCCs compared to normal liver tissue. RESULTS: Tumor suppressive effects, binding specificities, target genes, and regulated pathways of miR-449a and miR-449b differed from those of miR-449c. Transfection of miR-449a, miR-449b, and/or miR-449c inhibited cell proliferation and migration, induced apoptosis, and reduced tumor growth to different extents. Importantly, miR-449a, miR-449b, and, to a lesser degree, miR-449c directly targeted SOX4, which codes for a transcription factor involved in epithelial-mesenchymal transition and HCC metastasis, and thereby inhibited TGF-β-mediated cell migration. CONCLUSIONS: This study provides detailed insights into the regulatory network of the epigenetically regulated miRNA-449 family and, for the first time, describes distinct tumor suppressive effects and target specificities of miR-449a, miR-449b, and miR-449c. Our results indicate that particularly miR-449a and miR-449b may be considered for miRNA replacement therapy to prevent HCC progression and metastasis. LAY SUMMARY: In this study, we demonstrated that the microRNA-449 family acts as a tumor suppressor in liver cancer by causing cell death and inhibiting cell migration. These effects are caused by downregulation of the oncogene SOX4, which is frequently overexpressed in liver cancer. We conclude that the microRNA-449 family may be a target for liver cancer therapy.
引用
- Sandbothe M, Buurman R, Reich N, et al. The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4. J Hepatol. 2017. PMID: 28088579. doi:10.1016/j.jhep.2017.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。